Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mouth Neoplasms × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 77 Neoplasms, Plasma Cell 24 Central Nervous System Neoplasms 11 Glioblastoma 10 Recurrence 9 Neoplasms 9 Brain Neoplasms 9 Gliosarcoma 8 Carcinoma, Hepatocellular 8 Glioma 6 Waldenstrom Macroglobulinemia 5 Prostatic Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Leukemia 5 Carcinoma, Non-Small-Cell Lung 5 Lymphoma, Mantle-Cell 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Immunoglobulin Light-chain Amyloidosis 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Astrocytoma 4 Oligodendroglioma 3 Neuroblastoma 3 Myeloproliferative Disorders 3 Medulloblastoma 3 Kidney Neoplasms 3 Colonic Neoplasms 3 Breast Neoplasms 3

Interventions

Cisplatin 15 Cetuximab 10 Radiotherapy 9 Biopsy 9 Magnetic Resonance Spectroscopy 8 pembrolizumab 7 Surveys and Questionnaires 7 Radiotherapy, Intensity-Modulated 7 Radiation 7 Carboplatin 7 Surgical Procedures, Operative 6 Specimen Handling 6 Fluorouracil 6 Celecoxib 6 X-Rays 5 Standard of Care 5 Paclitaxel 5 Observation 5 Drug Therapy 5 Sentinel Lymph Node Biopsy 4 Interviews as Topic 4 Chemoradiotherapy 4 Watchful Waiting 3 Ultrasonography 3 Taxes 3 Practice Guidelines as Topic 3 Positron Emission Tomography Computed Tomography 3 Platinum 3 Optical Imaging 3 Metformin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡